recovery from liver dysfunction after adult isolated intestinal transplantation without liver grafting

Purpose: We sought to evaluate liver function recovery after isolated intestinal transplantation in adults with irreversible intestinal failure. Patients and Methods: Over a 5-year period, we transplanted 34 adult patients, 25 of whom received an isolated intestinal graft, 4 a multivisceral graft without a liver, and 5, a multivisceral graft with a liver. Among the group of patients transplanted with the isolated graft we selected 14 recipients with pretransplant liver dysfunction, namely, a serum bilirubin >2 mg/dL (normal value: 1.2) and/or transaminases >100 IU/mL (NV, 37/40). Other inclusion criteria were total parenteral nutrition, period > 3 months, no diagnosis of portal hypertension or cirrhosis. Two patients had biopsy-proven liver fibrosis. Results: At discharge, all patients recovered liver function to normal values: mean bilirubin blood level was 0.9 ± 0.96 mg/dL (range: 0.3-1.6) and mean transaminases were 26 ± 9 and 31 ± 18 IU/mL (range: 10-44/27-65). After a mean follow-up of 2 years, only one patient has an elevated alanine aminotransferase level without clinical signs of liver disease. Type of pretransplant liver disease did not impact on survival rates. Conclusion: In selected cases, an isolated intestinal or a multivisceral graft without a liver can represent a "liver salvage therapy" for an early failing liver in patients with irreversible intestinal failure. Pretransplant liver disease is not a negative prognostic factor. © 2006 Elsevier Inc. All rights reserved.